<p>Schrödinger（纳斯达克代码：SDGR - 获取免费报告）预计将在 2 月 26 日星期三市场收盘后公布其财报。分析师预计该公司每股收益为（$0.35），季度收入为 8320 万美元。对参与公司电话会议感兴趣的投资者可以使用此链接。</p>
<h2>Schrödinger 股价表现</h2>
<ul>
<li>AI 制药：通往 AI 驱动药物投资的两条路径</li>
</ul>
<p>纳斯达克 SDGR 的股票周一开盘价为 22.64 美元。该公司的市值为 16.5 亿美元，市盈率为-9.68，贝塔值为 1.61。该公司的 50 日移动平均价格为 22.19 美元，200 日移动平均价格为 20.52 美元。Schrödinger 的 52 周低点为 16.67 美元，52 周高点为 33.63 美元。</p>
<h2>分析师评级上调与下调</h2>
<p>多家研究公司最近对 SDGR 发表了评论。BMO 资本市场将 Schrödinger 的目标价从 25.00 美元上调至 28.00 美元，并在 11 月 13 日的报告中给予该股票 “跑赢大盘” 的评级。KeyCorp 将 Schrödinger 的目标价从 25.00 美元上调至 27.00 美元，并在 1 月 24 日的报告中给予该股票 “增持” 的评级。三位投资分析师对该股票给予持有评级，六位给予买入评级，一位给予强烈买入评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “适度买入”，共识目标价为 32.11 美元。</p>
<ul>
<li>尽管每股收益超预期，Simulations Plus 股票下跌 15%</li>
</ul>
<p><strong>查看我们关于 Schrödinger 的最新研究报告</strong></p>
<h2>关于 Schrödinger</h2>
<p>（获取免费报告）</p>
<p>Schrödinger, Inc 及其子公司开发基于物理的计算平台，能够发现用于药物开发和材料应用的新分子。该公司分为两个部门，软件和药物发现。软件部门专注于将其软件授权给生命科学和材料科学行业，以转变分子发现。</p>
<h2>精选故事</h2>
<ul>
<li>我们更看好的五只股票超过 Schrödinger</li>
<li>每股收益计算器：如何计算 EPS</li>
<li>为什么 Genuine Parts Company 现在是一个非常好的买入机会</li>
<li>2022-2025 年股市假期 - 纽约证券交易所和纳斯达克何时关闭</li>
<li>工业股悄然超越市场：3 只值得关注的股票</li>
<li>澳大利亚证券交易所（ASX）是什么</li>
<li>这 5 只能源股以增长潜力对冲通胀</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U0RHUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U0RHUg"/></p>
<ul>
<li>这里有 3 只 AI 药物发现股票值得你关注</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 Schrödinger 吗？</h2>
<p>在你考虑 Schrödinger 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而 Schrödinger 并不在名单上。</p>
<p>虽然 Schrödinger 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

SDGR

<p>Schrodinger（纳斯达克代码：SDGR）将于 2 月 26 日公布财报，预计每股亏损 0.35 美元，收入为 8320 万美元。该股开盘价为 22.64 美元，市值为 16.5 亿美元。分析师的共识评级为 “适度买入”，目标价为 32.11 美元。最近的升级包括 BMO 资本市场将目标价从 25 美元上调至 28 美元，以及 KeyCorp 将目标价从 25 美元上调至 27 美元。投资者可以通过提供的链接加入电话会议</p>

<p>Schrödinger (NASDAQ:SDGR - Get Free Report) is anticipated to announce its earnings results after the market closes on Wednesday, February 26th. Analysts expect the company to announce earnings of ($0.35) per share and revenue of $83.20 million for the quarter. Investors that are interested in participating in the company's conference call can do so using this link.</p>
<div class="lb-trans"><p>Schrödinger（纳斯达克代码：SDGR - 获取免费报告）预计将在 2 月 26 日星期三市场收盘后公布其财报。分析师预计该公司每股收益为（$0.35），季度收入为 8320 万美元。对参与公司电话会议感兴趣的投资者可以使用此链接。</p>
</div><h2>Schrödinger Price Performance</h2>
<div class="lb-trans"><h2>Schrödinger 股价表现</h2>
</div><ul>
<li>AI Pharma: 2 Paths to AI-Powered Drug Investment</li>
</ul>
<div class="lb-trans"><ul>
<li>AI 制药：通往 AI 驱动药物投资的两条路径</li>
</ul>
</div><p>Shares of NASDAQ SDGR opened at $22.64 on Monday. The stock has a market capitalization of $1.65 billion, a PE ratio of -9.68 and a beta of 1.61. The business has a fifty day moving average price of $22.19 and a two-hundred day moving average price of $20.52. Schrödinger has a fifty-two week low of $16.67 and a fifty-two week high of $33.63.</p>
<div class="lb-trans"><p>纳斯达克 SDGR 的股票周一开盘价为 22.64 美元。该公司的市值为 16.5 亿美元，市盈率为-9.68，贝塔值为 1.61。该公司的 50 日移动平均价格为 22.19 美元，200 日移动平均价格为 20.52 美元。Schrödinger 的 52 周低点为 16.67 美元，52 周高点为 33.63 美元。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级上调与下调</h2>
</div><p>A number of research firms have recently commented on SDGR. BMO Capital Markets boosted their price target on Schrödinger from $25.00 to $28.00 and gave the stock an &#34;outperform&#34; rating in a report on Wednesday, November 13th. KeyCorp boosted their price target on Schrödinger from $25.00 to $27.00 and gave the stock an &#34;overweight&#34; rating in a report on Friday, January 24th. Three investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $32.11.</p>
<div class="lb-trans"><p>多家研究公司最近对 SDGR 发表了评论。BMO 资本市场将 Schrödinger 的目标价从 25.00 美元上调至 28.00 美元，并在 11 月 13 日的报告中给予该股票 “跑赢大盘” 的评级。KeyCorp 将 Schrödinger 的目标价从 25.00 美元上调至 27.00 美元，并在 1 月 24 日的报告中给予该股票 “增持” 的评级。三位投资分析师对该股票给予持有评级，六位给予买入评级，一位给予强烈买入评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “适度买入”，共识目标价为 32.11 美元。</p>
</div><ul>
<li>Simulations Plus Stock Drops 15% Despite EPS Beat</li>
</ul>
<div class="lb-trans"><ul>
<li>尽管每股收益超预期，Simulations Plus 股票下跌 15%</li>
</ul>
</div><p><strong>View Our Latest Research Report on Schrödinger</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 Schrödinger 的最新研究报告</strong></p>
</div><h2>About Schrödinger</h2>
<div class="lb-trans"><h2>关于 Schrödinger</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.</p>
<div class="lb-trans"><p>Schrödinger, Inc 及其子公司开发基于物理的计算平台，能够发现用于药物开发和材料应用的新分子。该公司分为两个部门，软件和药物发现。软件部门专注于将其软件授权给生命科学和材料科学行业，以转变分子发现。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Schrödinger</li>
<li>Earnings Per Share Calculator: How to Calculate EPS</li>
<li>Why Genuine Parts Company Is a Royally Good Buy Right Now</li>
<li>Stock Market Holidays 2022-2025 - Here’s When the NYSE and NASDAQ Will be Closed</li>
<li>Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch</li>
<li>What is the Australian Securities Exchange (ASX)</li>
<li>These 5 Energy Stocks Hedge Inflation With Growth Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过 Schrödinger</li>
<li>每股收益计算器：如何计算 EPS</li>
<li>为什么 Genuine Parts Company 现在是一个非常好的买入机会</li>
<li>2022-2025 年股市假期 - 纽约证券交易所和纳斯达克何时关闭</li>
<li>工业股悄然超越市场：3 只值得关注的股票</li>
<li>澳大利亚证券交易所（ASX）是什么</li>
<li>这 5 只能源股以增长潜力对冲通胀</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U0RHUg" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=SDGR"/></p>
<ul>
<li>Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist</li>
</ul>
<div class="lb-trans"><ul>
<li>这里有 3 只 AI 药物发现股票值得你关注</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Schrödinger Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Schrödinger 吗？</h2>
</div><p>Before you consider Schrödinger, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Schrödinger 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Schrödinger wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而 Schrödinger 并不在名单上。</p>
</div><p>While Schrödinger currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Schrödinger 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Schrödinger (SDGR) 预计将在周三发布财报